8-K ·Filed Apr 17, 2026

IMAX

IMAX CORP
NEUTRAL
Impact 3/10
Horizondays Processed5mo ago SEC0001628280-26-025752
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for any updates on CEO Richard Gelfond's health and return timeline. While this is a routine interim arrangement, prolonged absence could prompt longer-term succession considerations. Recent insider selling activity ($4.5M in 30 days) may warrant additional scrutiny.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
IMAX ▲ +9.15% at T+60d
NEUTRAL call ✓ call won +9.15% · α vs SPY +2.37% · entry $35.95 → $39.24
Entry anchored
Apr 17, 03:59 PM ET
via exchange tick
T+1d
-0.56%
call -0.56% · α +0.10%
$35.75
settled 6mo ago
T+5d
+3.25%
call +3.25% · α +2.34%
$37.12
settled 5mo ago
T+20d
-4.73%
call -4.73% · α -8.93%
$34.25
settled 5mo ago
T+60d
+9.15%
call +9.15% · α +2.37%
$39.24
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

IMAX Corporation appointed Chief Legal Officer Robert D. Lister as interim principal executive officer while CEO Richard Gelfond is on temporary medical leave. Gelfond is expected to resume his role on May 1, 2026. Lister will not receive additional compensation for this temporary assignment.

Key Facts

  • CEO Richard Gelfond is on temporary medical leave, previously announced on March 30, 2026
  • Robert D. Lister, Chief Legal Officer and Senior Executive Vice President, appointed interim principal executive officer effective April 16, 2026
  • Lister will serve in this role until May 1, 2026, when Gelfond is expected to resume duties
  • No additional compensation will be paid to Lister for the interim role
  • No changes to other executive arrangements or plans were made in connection with this appointment

Financial Impact

No financial impact — interim appointment without additional compensation

executive leadershipgovernance

Risk Factors

  • Potential uncertainty regarding CEO Gelfond's health and long-term availability
  • Leadership transition risk if the interim period extends beyond May 1, 2026

Market Snapshot

Exchange
NYSE
Sector
Photographic Equipment & Supplies

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-025752
Document: 0001628280-26-025752-index-headers.html0001628280-26-025752
Document: 0001628280-26-025752-index.html0001628280-26-025752
Document: 0001628280-26-025752.txt0001628280-26-025752
6 reports for IMAX
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+20▲ +3.80%Mar 10, 2026
Filters
Rows
Reports for IMAX — sortable, filterable
TypeNow
Aug 26, 2026
5w ago
Insider Cluster
BEARISH ★ 5/10
$52.76 $55.16▼ −4.55%▼ −4.32%$52.52 (+0.45%)
Aug 21, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$52.74 $54.04▲ +2.46%▲ +2.99%$52.52 (−0.42%)
Apr 30, 2026
22w ago
8-K
MIXED ★ 5/10
$36.51 $40.49▲ +10.90%▲ +5.62%$52.52 (+43.85%)
Apr 17, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$35.95 $34.25▼ −4.73%▼ −8.93%$52.52 (+46.09%)
Mar 10, 2026
29w ago
Insider Cluster
BEARISH ★ 7/10
$39.71 $38.20▲ +3.80%▲ +3.65%$52.52 (−32.26%)
Feb 25, 2026
31w ago
8-K
BULLISH ★ 8/10
$41.77 $37.75▼ −9.62%▼ −3.22%$52.52 (+25.74%)
Showing 6 of 6

US Market Status

Market Closed — Opens Mon (37h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access